[IRS1](/entities/irs1) encodes insulin receptor substrate 1, a key adaptor protein that mediates signaling downstream of the insulin and insulin-like growth factor 1 (IGF-1) receptors.[@white1998] IRS-1 plays a central role in [brain insulin signaling](/entities/brain-insulin-signaling), and its dysfunction contributes to insulin resistance and metabolic disturbances observed in neurodegenerative diseases.[@talbot2012]
Structure and Expression
The IRS1 gene spans approximately 130 kb on chromosome 2q35 and contains multiple exons encoding a 1242-amino acid protein.[@araki1994] IRS-1 contains:
[IRS1](/entities/irs1) encodes insulin receptor substrate 1, a key adaptor protein that mediates signaling downstream of the insulin and insulin-like growth factor 1 (IGF-1) receptors.[@white1998] IRS-1 plays a central role in [brain insulin signaling](/entities/brain-insulin-signaling), and its dysfunction contributes to insulin resistance and metabolic disturbances observed in neurodegenerative diseases.[@talbot2012]
Structure and Expression
The IRS1 gene spans approximately 130 kb on chromosome 2q35 and contains multiple exons encoding a 1242-amino acid protein.[@araki1994] IRS-1 contains:
Glucose Metabolism: Mediates GLUT4 translocation and glucose uptake
Cell Growth: Activates MAPK pathway for proliferation and survival[@sun1991]
Role in Neurodegeneration
Brain Insulin Resistance
Reduced IRS-1 expression and increased inhibitory serine phosphorylation have been observed in postmortem brains of patients with neurodegenerative diseases, representing a form of central insulin resistance that impairs neuronal metabolism and survival.[@de1954]
Alzheimer's Disease
[Alzheimer's disease](/diseases/alzheimers-disease) is associated with brain insulin resistance characterized by IRS-1 dysfunction:[@moloney2010]
Reduced IRS-1 tyrosine phosphorylation in hippocampus and cortex
Impaired downstream AKT and [GSK-3β](/entities/gsk3-beta) signaling
Correlation with cognitive decline severity
[Amyloid-beta](/proteins/amyloid-beta) oligomers induce IRS-1 serine phosphorylation via inflammatory kinase activation, contributing to insulin resistance. IRS-1 dysfunction may enhance [tau](/proteins/tau) hyperphosphorylation through GSK-3β activation.
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), IRS-1 signaling is impaired in dopaminergic neurons and the substantia nigra.[@morris2011] This contributes to:
Energy metabolism deficits
Impaired [autophagy](/entities/autophagy)
Increased oxidative stress susceptibility
Mitochondrial dysfunction
Diabetes and Cognitive Decline
Type 2 diabetes is a major risk factor for cognitive impairment and dementia. Peripheral insulin resistance often accompanies brain insulin resistance, with IRS-1 dysfunction as a common mechanism.[@biessels2014] The APOE4 allele exacerbates IRS-1 dysfunction in AD brains.
[White MF, The IRS proteins and the common pathway of insulin action (1998)](https://doi.org/10.1002/jlb.65.5.641)
[Talbot K, Wang HY, Kazi H, et al, Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline (2012)](https://doi.org/10.1172/JCI59903)
[Araki E, Lipes MA, Patti ME, et al, Alternative pathway of insulin signalling in mice with targeted disruption of IRS-1 gene (1994)](https://doi.org/10.1038/372186a0)
[Patti ME, Kahn CR, Insulin signalling and the regulation of glucose and lipid metabolism (2001)](https://doi.org/10.1038/414799a)
[Sun XJ, Rothenberg P, Kahn CR, et al, Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein (1991)](https://doi.org/10.1038/352073a0)
[de Felice FG, Ferreira ST, Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease (1954)](https://doi.org/10.2337/db13-1954)
[Moloney AM, Griffin RJ, Timmons S, et al, Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling (2010)](https://pubmed.ncbi.nlm.nih.gov/20417636/)
[Morris JK, Bomhoff GL, Stanford JA, Gerhardt GA, Impaired dopaminergic neurotransmission and microglial activation in rats following chronic diabetes (2011)](https://pubmed.ncbi.nlm.nih.gov/21621680/)
[Biessels GJ, Strachan MW, Visseren FL, et al, Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions (2014)](https://doi.org/10.1016/S2213-8587(14)
[Taniguchi CM, Emanuelli B, Kahn CR, Critical nodes in signalling pathways: insights into insulin action (2006)](https://doi.org/10.1038/nrm2191)
[Boura-Halfon S, Zick Y, Phosphorylation of IRS proteins, insulin action, and insulin resistance (2008)](https://doi.org/10.1152/ajpendo.90436.2008)
[El Khoury NB, Gratuze M, Petry F, et al, Metformin promotes neurogenesis and enhances spatial memory formation in mice (2019)](https://doi.org/10.1007/s13311-019-00780-4)
[Aviles-Olmos I, Dickson J, Kefalopoulou Z, et al, Exenatide and the treatment of patients with Parkinson's disease (2014)](https://doi.org/10.1172/JCI72045)